FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 15 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $49,556 | -22.9% | 107,731 | -16.6% | 0.01% | -77.4% |
Q4 2022 | $64,313 | -30.1% | 129,169 | -2.1% | 0.06% | -26.2% |
Q3 2022 | $92,000 | -28.7% | 131,957 | -10.0% | 0.08% | -14.3% |
Q2 2022 | $129,000 | -20.4% | 146,562 | +1.3% | 0.10% | +28.9% |
Q1 2022 | $162,000 | -55.0% | 144,672 | -20.7% | 0.08% | -42.0% |
Q4 2021 | $360,000 | – | 182,521 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 1,466,507 | $6,217,990 | 9.26% |